Press release
Radiopharmaceuticals Market Size Forecasted To Achieve $10.59 Billion By 2029 With Steady Growth
Radiopharmaceuticals
How Big Is the Radiopharmaceuticals Market Size Expected to Be by 2034?
The radiopharmaceuticals market has shown steady growth, expected to rise from $6.46 billion in 2024 to $6.77 billion in 2025 at a CAGR of 4.7%. This expansion is attributed to increased healthcare spending, government initiatives, the convenience of treatment, and lifestyle changes.
The radiopharmaceuticals market is expected to grow rapidly, reaching $10.59 billion in 2029 with a CAGR of 11.8%. The growth is driven by the aging population, the increasing prevalence of cancer and heart disease, high investments, and new product innovations. Trends include company collaborations to boost revenue and product quality, expansion of plant capacities, AI-driven drug development, and innovations for cardiology treatments.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3471
What Are the Emerging Segments Within the Radiopharmaceuticals Market?
The radiopharmaceuticals market covered in this report is segmented -
1) By Type: Diagnostic, Therapeutic
2) By Application: Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Musculoskeletal, Respiratory, Nephrology, Other Applications
3) By End User: Hospitals And Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes
Subsegments:
1) By Diagnostic: Positron Emission Tomography (PET) Radiopharmaceuticals, Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
2) By Therapeutic: Alpha Emitters, Beta Emitters, Brachytherapy
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3471&type=smp
What Long-Term Drivers Are Shaping Radiopharmaceuticals Market Trends?
The radiopharmaceuticals market is anticipated to grow due to the increasing prevalence of cancer and cardiovascular diseases. Radiopharmaceuticals are emerging as an effective treatment option for these diseases, providing targeted therapies that offer advantages over conventional treatments. In April 2024, the International Agency for Research on Cancer (IARC) reported nearly 20 million new cancer cases in 2022, and the number is expected to increase to 29.9 million by 2040. This rising incidence of cancer and cardiovascular diseases is expected to drive the demand for radiopharmaceuticals.
Who Are the Top Competitors in Key Radiopharmaceuticals Market Segments?
Major companies operating in the radiopharmaceuticals market include Cardinal Health, Curium Pharma, Siemens Healthineers AG, Novartis AG, General Electric Company (GE), IBA Group, Bayer AG, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Eckert & Ziegler, Nihon Medi-Physics Co. Ltd., Fujifilm Corporation, ANSTO, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Bracco Imaging SpA., Canon Inc., China Isotope & Radiation Corporation (CIRC), Alliance Medical, Advanced Accelerator Applications, JSC Isotope, Pharm-Sintez, Synektik SA, Polatom, RadioMedic sro, ÚJV Rež, Actinium Pharmaceuticals Inc., Alseres Pharmaceuticals Inc., Avid Radiopharmaceuticals, Fusion Pharmaceuticals, Peregrine Pharmaceuticals Inc., PETNET Solutions Inc., Positron Corporation, Triad Isotopes Inc., Telix Pharmaceuticals, Rosatom, Alliance Medical Group, Hologic Inc., Segami Corporation, Eczacýbaþý-Monrol Nuclear Products, NTP Radioisotopes.
What Trends Are Expected to Dominate the Radiopharmaceuticals Market in the Next 5 Years?
Companies in the radiopharmaceuticals market are increasingly opening new manufacturing plants and expanding production capacity. For instance, ITM Isotopen Technologien Munchen AG (ITM) launched a new facility in Munich to increase production of high-purity Lutetium-177, used in cancer treatment. This move helps the company meet global demand for quality medical isotopes used in precision oncology.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-global-market-report
Which Regions Are Becoming Hubs for Radiopharmaceuticals Market Innovation?
The countries covered in the radiopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Radiopharmaceuticals Market?
2. What is the CAGR expected in the Radiopharmaceuticals Market?
3. What Are the Key Innovations Transforming the Radiopharmaceuticals Industry?
4. Which Region Is Leading the Radiopharmaceuticals Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceuticals Market Size Forecasted To Achieve $10.59 Billion By 2029 With Steady Growth here
News-ID: 4060678 • Views: …
More Releases from The Business Research Company
Increasing Prevalence Of Nasal Disorders Driving Growth Of The Market: A Signifi …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Rhinoscope Devices Market Size and Projected Growth Rate?
The market size for rhinoscope devices has seen significant growth over the past few years. It's projected to increase from $4.74 billion in 2024 to $5.09 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.3%. Several factors contribute…
Emerging Trends Influencing The Growth Of The Astigmatism Market: Innovative Con …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Astigmatism Market Size Expected to Be by 2034?
In recent times, the market for astigmatism has seen robust growth. The projection is that it will expand from $3.03 billion in 2024 to $3.22 billion in 2025, with a compound annual growth rate (CAGR) of 6.5%. The former period's…
Recurrent Head And Neck Cancer Squamous Cell Carcinoma Industry Report 2025-2034 …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Expected Recurrent Head And Neck Cancer Squamous Cell Carcinoma Market Size During the Forecast Period?
There has been a significant surge in the market size of squamous cell carcinoma, specifically recurrent head and neck cancer, over recent years. It's projected to climb from $3.10 billion in 2024 to $3.33…
Presbyopia Market Size Projected To Reach 13.3 Billion By 2034 With A Cagr Of 5. …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Presbyopia Market?
In recent times, the presbyopia market size has experienced significant growth. The market value is set to rise from $10.11 billion in 2024 to $10.70 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.8%. Factors such as the escalating prevalence…
More Releases for Radiopharmaceuticals
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029
The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors.
Market Analysis and Size
The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029.
Gets a Sample Copy of the Nuclear…
Diagnostic Radiopharmaceuticals Market 2021 | Detailed Report
According to Market Study Report, Diagnostic Radiopharmaceuticals Market provides a comprehensive analysis of the Diagnostic Radiopharmaceuticals Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Diagnostic Radiopharmaceuticals Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4645020
The report provides a comprehensive analysis of…
Global Radiopharmaceuticals Market 2017-2021
About Radiopharmaceuticals
Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand…
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Global Radiopharmaceutical Market Overview
1.1 Current Market Scenario
1.2 Diagnostic & Therapeutic Radiopharmaceuticals
1.3 Global Radiopharmaceticals Clinical Pipeline Overview
2. Global Radiopharmaceuticals Market Dynamics
3. Radioisotopes Used in Radiopharmaceuticals
4. EMA Guidelines for Radiopharmaceuticals
4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products
4.2 Toxicological & Pharmacological Tests
4.3 Clinical Documentation
4.4 Radiation…
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use…
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a…
